PLAU 抗体 (AA 179-431)
(1 reference)Quick Overview for PLAU 抗体 (AA 179-431) (ABIN5692920)
抗原
See all PLAU 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 179-431
-
原理
- Anti-PLAU Antibody Picoband®
-
交叉反应 （详细）
- No cross-reactivity with other proteins.
-
产品特性
- Anti-PLAU Antibody Picoband® (ABIN5692920). Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
-
免疫原
- E. coli-derived human PLAU recombinant protein (Position: I179-L431).
-
亚型
- IgG
-
-
anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90), (N-Term) antibody
PLAU 适用: 人, 小鼠 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB04087 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (C-Term) antibodyVerified PLAU 适用: 人 ELISA, IHC 宿主: 山羊 Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426) antibodyPLAU 适用: 人 WB, ELISA, IHC, FACS, IF 宿主: 兔 Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90) antibodyPLAU 适用: 人, 小鼠 WB, ELISA, IHC, FACS 宿主: 兔 Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 180-433) antibodyPLAU 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 16-115) antibodyPLAU 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 3B8 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) antibodyPLAU 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426), (C-Term) antibodyPLAU 适用: 人 WB, FACS, IHC (p), IF 宿主: 兔 Polyclonal RB04089-04090 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 17-432) antibodyPLAU 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 21-173) antibodyPLAU 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Western blot, 0.1-0.5 μg/mL
ELISA, 0.1-0.5 μg/mL
1. Degryse, Bernard (1 June 2011). "The urokinase receptor system as strategic therapeutic target: challenges for the 21st century". Current Pharmaceutical Design. 17 (19): 1872-1873. 2. Tang, Linlin, Han, Xiuzhen (March 2013). "The urokinase plasminogen activator system in breast cancer invasion and metastasis". Biomedicine & Pharmacotherapy. 67 (2): 179-182. -
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
浓度
- 500 μg/mL
-
缓冲液
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
-
-
-
: "Effects of Guiyuanfang and autologous transplantation of bone marrow stem cells on rats with liver fibrosis." in: World journal of gastroenterology, Vol. 11, Issue 8, pp. 1155-60, (2005) (PubMed).
-
: "Effects of Guiyuanfang and autologous transplantation of bone marrow stem cells on rats with liver fibrosis." in: World journal of gastroenterology, Vol. 11, Issue 8, pp. 1155-60, (2005) (PubMed).
-
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
别名
- PLAU
-
背景
-
Synonyms: Urokinase-type plasminogen activator, U-plasminogen activator, uPA, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A, Urokinase-type plasminogen activator chain B, PLAU
Tissue Specificity: Expressed in the prostate gland and prostate cancers.
Background: Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.
-
分子量
- 48 kDa
-
基因ID
- 5328
-
UniProt
- P00749
-
途径
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
抗原
-
